Enquiry/Quote

How to Source Moxifloxacin Injection for Pharmaceutical Formulation

Moxifloxacin Injection (IV Infusion, 400 mg/250 mL) is classified under Respiratory Disorder. It is therapeutically aligned with reference brands such as Avelox®, Avalox®(EU); Avelox®, Vigamox®(US), Moxicip (India). This guide highlights key sourcing factors buyers should consider when procuring high-quality Moxifloxacin Injection for formulation, R&D, or bulk manufacturing.

Product Overview: Moxifloxacin is a broad-spectrum fluoroquinolone antibiotic used for respiratory, sinus, and skin infections. Available in the US and EU as 400 mg tablets, IV infusion, and 0.5% eye drops, it's sold under brands like Avelox® and Vigamox®. Ideal for B2B, PCD, and global pharma markets. Moxifloxacin is a fourth-generation fluoroquinolone antibiotic used to treat respiratory tract infec...

Moxifloxacin Injection API in IV Infusion form, 400 mg/250 mL specification
Moxifloxacin Injection API – ideal for compliant pharmaceutical formulation.
Quick Insight: Over 60% of formulation delays are linked to poor API sourcing. A well-planned sourcing strategy can reduce risk and accelerate market entry.

1. Regulatory Compliance & Documentation

Ensure suppliers provide:

2. Purity, Grade & Specification Matching

Moxifloxacin Injection must meet exact grade and purity for your dosage form:

3. Supplier Reliability & Audit History

4. Commercial Terms: Pricing, MOQ & Flexibility

5. Lead Time, Inventory & Logistics

Typical lead time for Moxifloxacin Injection is 4–6 weeks.

6. Formulation Support

Pro Tip: Engage supplier formulation experts early — it can improve bioavailability and cut development time.

Conclusion

Sourcing Moxifloxacin Injection is more than procurement—it’s a strategic partnership. With its iv infusion form and 400 mg/250 mL specification, choosing a compliant supplier ensures consistent quality and regulatory approval. Prioritize documentation, verify compatibility, and build relationships with transparent, reliable suppliers to secure long-term success.

Next Step: Get expert assistance in sourcing Moxifloxacin Injection.

Request a Quote

Frequently Asked Questions For Sourcing of Moxifloxacin Injection

What is the typical lead time for Moxifloxacin Injection?

Lead times range from 4–6 weeks depending on supplier and region.

Is Moxifloxacin Injection available in multiple grades?

Yes — common grades include USP, EP, and JP. Verify grade suitability for your dosage form before purchase.

Does Moxifloxacin Injection require special storage?

It should be stored in a cool, dry place away from direct sunlight.

Is a Drug Master File (DMF) available for Moxifloxacin Injection?

Yes, a DMF is available for regulated markets upon request. It includes detailed quality, manufacturing, and stability data.

Can I request samples or a pilot batch of Moxifloxacin Injection?

Yes — pilot batches or samples can be arranged for R&D, stability studies, or formulation trials. MOQ may vary based on region and regulatory scope.

What compliance certificates are available for Moxifloxacin Injection?

Available documentation may include GMP, ISO 9001, ISO 14001, and ICH Q7 certificates, along with CoA, TDS, and stability data.

Is Moxifloxacin Injection suitable for regulated markets like US/EU?

Yes — compliant with EU/US/WHO GMP standards and available with regulatory support documentation for filings.

Can Moxifloxacin Injection be used in fixed-dose combinations?

Yes — many formulations support inclusion in FDCs. Compatibility studies and formulation consultation are available on request.

Subscribe to Our Newsletter

Stay updated on pharma trends and marketplace opportunities.

Please enter the correct answer.
This website uses cookies to ensure you get the best experience. By using our site, you agree to our Privacy Policy.